Notice: unserialize(): Error at offset 2 of 31 bytes in /data/html/www_bioworld_com/includes/bootstrap.inc on line 559 Notice: unserialize(): Error at offset 2753 of 5598 bytes in /data/html/www_bioworld_com/includes/bootstrap.inc on line 559 VCs 'BET' $19M on Oncoethix's Hematological Cancer Candidate | BioWorld

Login to Your Account



VCs 'BET' $19M on Oncoethix's Hematological Cancer Candidate

By Cormac Sheridan
Staff Writer

Wednesday, July 10, 2013
Oncoethix SA raised CHF18 million (US$18.7 million) in a Series B round to move its bromodomain and extra-terminal (BET) inhibitor OTX015 into Phase II proof-of-concept studies in hematological malignancies.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription